Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules

Current Opinion in Cell Biology

Volumn 9, Issue 5, 1997, Pages 643-650

  Gahmberg, Carl G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11 ANTIGEN; CD11B ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL MEMBRANE FLUIDITY; EXTRACELLULAR MATRIX; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; TARGET CELL;

ANIMALIA;

EID: 0030854195     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(97)80117-2     Document Type: Article

References (47)

1. Kansas GS: Selectins and their ligands: current concepts and controversies. Blood 1996, 88:3259-3287.
2. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2101.
3. Diamond MS, Springer TA: The dynamic regulation of integrin adhesiveness. Curr Biol 1994, 4:506-517.
4. Stewart M, Thiel M, Hogg N: Leukocyte integrins. Curr Opin Cell Biol 1995, 7:690-696.
5. Humphries MJ: Integrin activation: the link between ligand binding and signal transduction. Curr Opin Cell Biol 1996, 8:632-640.
6. Gahmberg CG, Tolvanen M, Kotovuori P: Leukocyte adhesion. Structure and function of human leukocyte β2-integrins and their cellular ligands. Eur J Biochem 1997, 245:215-232.
7. Dunon D, Piali L, Imhof BA: To stick or not to stick: the new leukocyte homing paradigm. Curr Opin Cell Biol 1996, 8:714-723.
8. Stewart M, Hogg N: Regulation of leukocyte integrin function: affinity vs. avidity. J Cell Biochem 1996, 61:554-561.
9. 2+ or by an increased avidity as seen after activation with phorbol esters.
10. Helander TS, Carpén O, Turunen O, Kovanen PE, Vaheri A, Timonen T: ICAM-2 redistributed by ezrin as a target for killer cells. Nature 1996, 382:265-268. It is shown that the cytoskeletal protein ezrin is able to induce the formation of uropods on target cells and brings the integrin ligand ICAM-2 to these structures. This increases the susceptibility of target cells to cytotoxicity.
11. Del Pozo MA, Cabañas C, Montoya MC, Ager A, Sánchez-Mateos P, Sánzes-Madrid F: ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes. J Cell Biol 1997, 137:493-508.
12. Heiska L, Kantor C, Parr T, Critchley DR, Vilja P, Gahmberg CG, Carpén O: Binding of the cytoplasmic domain of intercellular adhesion molecule-2 (ICAM-2) to ́-actinin. J Biol Chem 1996, 271:26214-26219.
13. Holland J, Owens T: Signaling through intercellular adhesion molecule 1 (ICAM-1) in a B cell lymphoma line. J Biol Chem 1997, 272:9108-9112. Cross-linking of ICAM-1 resulted in increased tyrosine phosphorylation of many unidentified proteins and activation of serine-threonine kinases.
14. Li R, Xie J, Kantor C, Koistinen V, Altieri DC, Nortamo P, Gahmberg CG: A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18. J Cell Biol 1995, 129:1143-1153.
15. Buckley CD, Ferguson ED, Littler AJ, Bossy D, Simmons DL: Role of ligands in the activation of LFA-1. Eur J Immunol 1997, 27:957-962. Evidence was obtained that CD11a/CD18 can exist in at least two different states of activation.
16. Zhang L, Plow EF: A discrete site modulates activation of I domains. J Biol Chem 1996, 271:29953-29957. The authors of this paper used mutational analysis to demonstrate that two loops from the CD11b/CD18 integrin I domain can regulate integrin activity. The work suggests that binding of ligand could alter I domain structure, resulting in integrin activation.
17. Carr MW, Alon R, Springer TA: The C-C chemokine MCP-1 differentially modulates the avidity of β1 and β2 integrins on T lymphocytes. Immunity 1996, 4:179-187.
18. Weber C, Kitayama J, Springer TA: Differential regulation of β1 and β2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci USA 1996, 93:10939-10944.
19. Kolanus W, Nagel W, Schiller B, Zeitlmann L, Godar S, Stodinger H, Seed B: αLβ2 integrin/LPA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 1996, 86:233-242. The cytoplasmic protein cytohesin-1 is described in this paper. Cytohesin-1 activates leukocyte integrins from the inside of the cell. If the pleckstrin homology domain alone of cytohesin-1 was overexpressed, adhesion was inhibited, probably by competitive inhibition.
20. Molica S, Dattilo A, Mannella A, Levato D: Intercellular adhesion molecules (ICAMs) 2 and 3 are frequently expressed in B cell chronic lymphocytic leukemia. Leukemia 1996, 10:907-908.
21. Patey N, Vazeux R, Canioni D, Potter T, Gallatin WM, Brousse N: Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responses. Am J Pathol 1996, 148:465-472.
22. Bailly P, Tontti E, Hermand P, Cartron J-P, Gahmberg CG: The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol 1995, 25:3316-3320.
23. Yoshihara Y, Oka S, Nemoto Y, Watanabe Y, Nagata S, Kagamiyama H, Mori K: An ICAM-related neurone glycoprotein, telencephalin, with brain segment-specific expression. Neuron 1994, 12:541-553.
24. Mizuno T, Yoshihara Y, Inazawa J, Kagamiyama H, Mori K: cDNA cloning and chromosomal localization of the human telencephalin and its distinctive interaction with lymhocyte function-associated antigen-1. J Biol Chem 1997, 272:1156-1163. Describes the cloning of the cDNA encoding human telencephalin and its localization to chromosome 19p13.2, the chromosomal region where the genes for ICAM-1, ICAM-3 and ICAM-4 are also located.
25. Tian L, Yoshihara Y, Mizuno T, Mori K, Gahmberg CG: The neuronal glycoprotein telenchephalin is a cellular ligand for the CD11a/CD18 leukocyte integrin. J Immunol 1997, 158:928-936. The binding of telencephalin to CD11a/CD18 was demonstrated. Telencephalin is the first brain-specific ICAM molecule, and intriguing questions are raised about its possible functions.
26. Duperray A, Languino LR, Plescia J, McDowall A, Hogg N, Craig AG, Berendt AR, Altieri DC: Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem 1997, 272:435-441. These authors characterized the binding of fibrinogen to ICAM-1 by using monoclonal antibodies. This binding may be important in wound healing and perhaps in the development of atherosclerotic plaques.
27. D'Souza SE, Byers-Ward VJ, Gardiner EE, Wang H, Sung S-S: Identification of an active sequence within the first immunoglobulin domain of intercellular cell adhesion molecule-1 (ICAM-1) that interacts with fibrinogen. J Biol Chem 1996, 271:24270-24277. Here the binding sites for fibrinogen in ICAM-1 were mapped in detail using blocking peptides and antibodies.
28. Holness CL, Bates PA, Littler AJ, Buckley CD, McDowall A, Bossy D, Hogg N, Simmons DL: Analysis of the binding site on intercellular adhesion molecule 3 for the leukocyte integrin lymphocyte function-associated 1. J Biol Chem 1995, 270:877-884.
29. Klickstein LB, York MR, de Fougerolles AR, Singer TA: Localization of the binding site on intercellular adhesion molecule-3 (ICAM-3) for lymphocyte function-associated antigen 1 (LFA-1). J Biol Chem 1996, 271:23920-23927.
30. Casasnovas JM, Springer TA, Liu J-H, Harrison SC, Wang J-H: Crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature 1997, 387:312-315. Here, for the first time, the three-dimensional structure of the external part of an ICAM molecule is described. The binding region for integrins is rather flat and this region lacks the protruding loop seen in VCAM-1; this region is probably important for binding. In contrast to the first domains of ICAM-2 and VCAM-1 which are rather different, probably reflecting different functions, the second domains are quite similar.
31. Li R, Nortamo P, Valmu L, Tolvanen M, Kantor C, Gahmberg CG: A peptide from ICAM-2 binds to the leukocyte integrin CD11a/CD18 and inhibits endothelial cell adhesion. J Biol Chem 1993, 268:17513-17518.
32. Lub M, van Kooyk Y, Figdor CG: Competition between lymphocyte function-associated antigen 1 (CD11a/CD18) and Mac-1 (CD11b/CD18) for binding to intercellular adhesion molecule-1 (CD54). J Leukoc Biol 1996, 59:648-655.
33. Driessens MHE, van Hulten P, Zuurbier A, La Rivière G, Roos E: Inhibition and stimulation of LFA-1 and Mac-1 functions by antibodies against murine CD18. Evidence that the LFA-1 binding sites for ICAM-1, -2, and -3 are distinct J Leukoc Biol 1996, 60:758-765.
34. Van Kooyk Y, Binnerts ME, Edwards CP, Champe M, Berman PW, Figdor CG, Bodary SC: Critical amino acids in the lymphocyte function-associated antigen-1 I domain mediate intercellular adhesion molecule 3 binding and immune function. J Exp Med 1996, 183:1247-1252.
35. Binnerts ME, van Kooyk Y, Edwards CP, Champe M, Presta L, Bodary SC, Figdor CG, Berman PW: Antibodies that selectively inhibit leukocyte function-associated antigen 1 binding to intercellular adhesion molecule-3 recognize a unique epitope within the CD11a I-domain. J Biol Chem 1996, 271:9962-9968.
36. Goodman TG, Bajt ML: Identifying the putative metal ion-dependent adhesion site in the β2 (CD18) subunit required for αLβ2 and αMβ2 ligand interactions. J Biol Chem 1996, 271:23729-23736.
37. Springer TA: Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain. Proc Natl Acad Sci USA 1997, 94:65-72. The proposal is made that the amino-terminal part of an integrin a subunit forms a β-propeller-like structure, which may resemble G proteins. Although still hypothetical, this proposal is interesting and certainly stimulates research on this topic.
38. Huang C, Lu C, Springer TA: Folding of the conserved domain but not of flanking regions in the integrin β2 subunit requires association with the α subunit. Proc Natl Acad Sci USA 1997, 94:3156-3161. In this paper and [39], monoclonal antibodies were used to probe the folding of CD18 and CD11a polypeptides during integrin biosynthesis.
39. Huang C, Springer TA: Folding of the β-propeller domain of the integrin αL subunit is independent of the I domain and dependent on the β2 subunit Proc Natl Acad Sci USA 1997, 94:3162-3167.
40. Bullard DC, Scharffetter-Kochanek K, McArthur MJ, Chosay JG, McBride ME, Montgomery CA, Beaudet AL: A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc Natl Acad Sci USA 1996, 93:2116-2121. Homozygous 129/Sv mice lacking the CD18 gene showed, as expected, a number of defects in leukocyte functions. However, when mice of this strain were backcrossed into the PL/J strain, the next generation mice developed a psoriasis-like skin disease. The finding shows the importance of CD11/CD18 integrins but also that other gene products are involved in the development of this skin disease.
41. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Amaout MA, Mayadas TN: A novel role for the β2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 1996, 5:653-666. This paper describes results that indicate an important role of CD11b/CD18 in apoptosis.
42. Van der Vieren M, Le Trong H, Wood CL, Moore PF, St John T, Staunton DE, Gallatin WM: A novel leukointegrin, αdβ2, binds preferentially to ICAM-3. Immunity 1995, 3:683-690.
43. El-Gabalawy H, Canvin J, Ma GM, Van der Vieren M, Hoffman P, Gallatin M, Wilkins JA: Synovial distribution of αd/CD18, a novel leukointegrin. Arthritis Rheum 1996, 39:1913-1921.
44. Connolly ES Jr, Winfree CJ, Springer TA, Naka Y, Liao H, Yan SD, Stem DM, Solomon RA, Gutierrez-Ramos J-C, Pinsky DJ: Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. J Clin Invest 1996, 97:209-216.
45. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutiérraz-Ramos J-C, Bonventre JV: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996, 97:1056-1063.
46. McDonagh PF, Wilson DS, Iwamura H, Smith CW, Williams SK, Copeland JG: CD18 antibody treatment limits early myocardial reperfusion injury after initial leukocyte deposition. J Surg Res 1996, 64:139-149.
47. Ginsberg MH, Ruggeri ZM, Varki AP: Cell adhesion in vascular biology: series introduction. J Clin Invest 1996, 98:1505. Since October 1996 this journal has published a number of important reviews on leukocyte adhesion. The reader is strongly advised to read these articles.